Stay informed with the latest litigation news. Explore now
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry Disease - EP3914247B1
EP3914247
- Application Number
- EP20708283A
- Filing Date
- Jan 22, 2020
- Status
- Granted And Under Opposition
- Oct 11, 2024
- Grant Date
- Nov 13, 2024
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3914247B1 was granted to Amicus Therapeutics on Nov 13, 2024 following the initial filing on Jan 22, 2020 under the application number EP20708283A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary
Patent Family New
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents